Nan Zhang1, Zhi Ping Ma2, Ju Wang3, Hui Li Bai4, Yi Xin Li5, Qin Sun6, Lan Yang5, Lin Tao5, Jin Zhao5, Yu Wen Cao5, Feng Li5, Wen Jie Zhang5. 1. Department of Pathology and The Key Laboratories for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of MedicineShihezi 832002, Xinjiang, China; Department of Pathology, The First Affiliated University Hospital, Shihezi University School of MedicineShihezi 832002, Xinjiang, China; Current Address: Zhengzhou Central HospitalZhengzhou 450007, Henan, China. 2. Department of Pathology and The Key Laboratories for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of MedicineShihezi 832002, Xinjiang, China; Department of Pathology, The First Affiliated University Hospital, Xinjiang Medical UniversityUrumqi 830054, Xinjiang, China. 3. Department of Histology and Embryology, Shihezi University School of Medicine Shihezi 832002, Xinjiang, China. 4. Department of Pathology and The Key Laboratories for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of MedicineShihezi 832002, Xinjiang, China; Department of Pathology, Zhengzhou Central HospitalZhengzhou 450007, Henan, China. 5. Department of Pathology and The Key Laboratories for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of MedicineShihezi 832002, Xinjiang, China; Department of Pathology, The First Affiliated University Hospital, Shihezi University School of MedicineShihezi 832002, Xinjiang, China. 6. Department of Mental Health Center, Hubei General Hospital, Wuhan University School of Medicine Wuhan 430060, Hubei, China.
Abstract
OBJECTIVES: Microbiota has been suggested in promoting chronic inflammation in human tissues which, in turn, promotes tumor development. This study tests a hypothesis that high-risk human papillomavirus (HR-HPV) infection may correlate with proinflammatory Stat3 signaling activities and IL-17 levels in breast cancer (BC) patients. MATERIALS AND METHODS: This study examined HPV infection by GenChip technology, constitutively active Stat3 (p-Stat3) and IL-17 levels by immunohistochemistry (IHC) using specific antibodies in 379 BC patients, together with 245 paired adjacent breast adenosis (ABA) tissues and 100 unrelated breast adenosis (BA) tissues. RESULTS: We obtained four major findings: (1) HR-HPV16/18 infections existed in 10.5% (34/325) of BC issues, higher than control BA tissues (4%, 4/100, P = 0.047). (2) Using IHC methodology, BC tissues showed more overactive p-Stat3 (2+/3+, 38.5%, 146/379) than ABA tissues (27.3%, 67/245, P < 0.001); similarly, BC also had more tissues overexpressing IL-17 (2+/3+, 61.5%, 233/379) than ABA tissues (51.8%, 127/245, P < 0.001). (3) High levels (2+/3+) of both active p-Stat3 and IL-17 correlated with poor differentiation and lymph nodal metastasis in BC (both with P < 0.05), but not with patients' prognosis. (4) HR-HPV infections correlated with both active p-Stat3 (P = 0.018) and its downstream IL-17 levels (P = 0.021) in BC tissues. CONCLUSION: There may be a possible tri-lateral relationship among HPV infection, constitutive Stat3 activity and IL-17 level, whose collaborations could orchestrate a proinflammatory microenvironment in breast tissues by which promote carcinogenesis and/or facilitate progression of breast cancer.
OBJECTIVES: Microbiota has been suggested in promoting chronic inflammation in human tissues which, in turn, promotes tumor development. This study tests a hypothesis that high-risk humanpapillomavirus (HR-HPV) infection may correlate with proinflammatory Stat3 signaling activities and IL-17 levels in breast cancer (BC) patients. MATERIALS AND METHODS: This study examined HPV infection by GenChip technology, constitutively active Stat3 (p-Stat3) and IL-17 levels by immunohistochemistry (IHC) using specific antibodies in 379 BC patients, together with 245 paired adjacent breast adenosis (ABA) tissues and 100 unrelated breast adenosis (BA) tissues. RESULTS: We obtained four major findings: (1) HR-HPV16/18 infections existed in 10.5% (34/325) of BC issues, higher than control BA tissues (4%, 4/100, P = 0.047). (2) Using IHC methodology, BC tissues showed more overactive p-Stat3 (2+/3+, 38.5%, 146/379) than ABA tissues (27.3%, 67/245, P < 0.001); similarly, BC also had more tissues overexpressing IL-17 (2+/3+, 61.5%, 233/379) than ABA tissues (51.8%, 127/245, P < 0.001). (3) High levels (2+/3+) of both active p-Stat3 and IL-17 correlated with poor differentiation and lymph nodal metastasis in BC (both with P < 0.05), but not with patients' prognosis. (4) HR-HPV infections correlated with both active p-Stat3 (P = 0.018) and its downstream IL-17 levels (P = 0.021) in BC tissues. CONCLUSION: There may be a possible tri-lateral relationship among HPV infection, constitutive Stat3 activity and IL-17 level, whose collaborations could orchestrate a proinflammatory microenvironment in breast tissues by which promote carcinogenesis and/or facilitate progression of breast cancer.
Entities:
Keywords:
IL-17; Inflammation; breast cancer; high-risk HPV; p-Stat3; prognosis
Authors: Joana Pinto Couto; Laura Daly; Ana Almeida; Jeffrey A Knauf; James A Fagin; Manuel Sobrinho-Simões; Jorge Lima; Valdemar Máximo; Paula Soares; David Lyden; Jacqueline F Bromberg Journal: Proc Natl Acad Sci U S A Date: 2012-08-13 Impact factor: 11.205
Authors: Luciana Benevides; Cristina R B Cardoso; Daniel G Tiezzi; Heitor R C Marana; Jurandyr M Andrade; João S Silva Journal: Eur J Immunol Date: 2013-05-16 Impact factor: 5.532
Authors: Annika Antonsson; Seweryn Bialasiewicz; Rebecca J Rockett; Kevin Jacob; Ian C Bennett; Theo P Sloots Journal: PLoS One Date: 2012-08-15 Impact factor: 3.240
Authors: Andreína Fernandes; Adriana Pesci-Feltri; Isabel García-Fleury; Marco López; Vincent Guida; Marisol De Macedo; María Correnti Journal: World J Clin Oncol Date: 2018-11-10
Authors: Diogo Alpuim Costa; José Guilherme Nobre; Marta Vaz Batista; Catarina Ribeiro; Catarina Calle; Alfonso Cortes; Maximilian Marhold; Ida Negreiros; Paula Borralho; Miguel Brito; Javier Cortes; Sofia Azambuja Braga; Luís Costa Journal: Front Microbiol Date: 2021-02-25 Impact factor: 5.640
Authors: Sarah Q To; Rhynelle S Dmello; Anna K Richards; Matthias Ernst; Ashwini L Chand Journal: Cancers (Basel) Date: 2022-01-15 Impact factor: 6.639